ClinicalTrials.govpublic full text
Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer
mesothelioma, mesothelioma, malignant, mesothelioma; pleura, mesotheliomas pleural, mesothelioma peritoneum, cholangiocarcinoma, cholangiocarcinoma recurrent, ovarian cancer, non small cell lung cancer, non small cell lung cancer metastatic, high grade ovarian serous adenocarcinoma, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 849590
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.